Results 281 to 290 of about 295,913 (316)

SLC12A9 Is an Immunological and Prognostic Biomarker for Glioma

Gene
Glioma is one of the most common malignant brain tumors. It has a high rate of progression and a poor prognosis, and effective biomarkers still need to be identified. The solute carrier family 12 (SLC12) family has been reported to be involved in various physiological and pathological processes, but their functional roles in glioma remain unclear.Using
Danting Li, Peilin Zheng, Shoujun Huang
openaire   +2 more sources

Biomarker: Predictive or Prognostic?

Journal of Clinical Oncology, 2015
To demonstrate that a biomarker is predictive of treatment benefit, the study requires biomarker status on all patients as well as patients who were treated with the agent of interest and patients not so treated, preferably in the context of a randomized study.
openaire   +2 more sources

Prognostic factors and biomarkers of penile carcinoma

Expert Opinion on Medical Diagnostics, 2008
Penile squamous cell carcinoma (SCC) is a rare malignancy with highest incidence in underdeveloped and developing countries. Oncogenic human papilloma virus (HPV) DNA, mainly types 16 and 18, are found in ∼ 100% of patients with uterine cervix carcinoma. The incidence of this virus in SCC and its variations range from 30.5 to 80%. Despite controversies,
openaire   +2 more sources

Predictive and prognostic biomarkers in urological tumours

Pathology
Advancements in cutting-edge molecular profiling techniques, such as next-generation sequencing and bioinformatic analytic tools, have allowed researchers to examine tumour biology in detail and stratify patients based on factors linked with clinical outcome and response to therapy. This manuscript highlights the most relevant prognostic and predictive
Alessia, Cimadamore, Carmine, Franzese, Carla, Di Loreto, Ana, Blanca, Antonio, Lopez-Beltran, Alessandro, Crestani, Gianluca, Giannarini, Puay Hoon, Tan, Benedito A, Carneiro, Wafik S, El-Deiry, Rodolfo, Montironi, Liang, Cheng   +11 more
openaire   +2 more sources

Predictive and prognostic molecular biomarkers in lymphomas

Pathology
Recent advances in molecular diagnostics have markedly expanded our understanding of the genetic underpinnings of lymphomas and catalysed a transformation in not just how we classify lymphomas, but also how we treat, target, and monitor affected patients.
J. Bryan Iorgulescu, L. Jeffrey Medeiros, Keyur P. Patel   +2 more
openaire   +2 more sources

Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma

Bioengineered, 2022
Heping Kan
exaly  

Validating fatty acid binding protein 3 as a diagnostic and prognostic biomarker for peripheral arterial disease: a three-year prospective follow-up study

EClinicalMedicine, 2023
Abdelrahman Zamzam, Muzammil H Syed, Ori D Rotstein   +2 more
exaly  

Prognostic Value of Cardiovascular Biomarkers

JAMA
Wen-Jun, Tu, Jizong, Zhao
openaire   +4 more sources

Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studies

Research Methods in Medicine & Health Sciences, 2023
Byron J Gajewski
exaly  

Prognostic nutritional index before surgical treatment may serve as a prognostic biomarker for patients with upper tract urothelial carcinoma: A systematic review and meta-analysis

Frontiers in Nutrition, 2022
Chunyang Meng, Lijian Gan, Kangsen Li
exaly